Tarsus Pharmaceuticals Inc Capital Reinvestment Ratio
Tarsus Pharmaceuticals Inc capital reinvestment ratio. Tarsus Pharmaceuticals Inc (TARS) has a Capital Reinvestment Ratio of 0.06x as of June 2026, meaning it reinvests 0% of its operating cash flow ($66.77 Million) in capital expenditures ($4.07 Million). See free cash flow generation of Tarsus Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tarsus Pharmaceuticals Inc (2021–2021)
Capital reinvestment ratio of Tarsus Pharmaceuticals Inc from 2021 to 2021. This chart tracks Tarsus Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. See Tarsus Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Tarsus Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2021–2021)
Tarsus Pharmaceuticals Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see TARS cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.16x | $3.75 Million | $586.00K | — |